Table 1.
Comparison of high and low care utilisation. PM Pacemaker, ICD implantable cardioverter-defibrillator
| All patients (n = 202) | Low care utilisation (n = 186 (92%)) | High care utilisation (n = 16 (8%)) | p | |
|---|---|---|---|---|
| Median age, years | 41 (18–78) | 40 (18–78) | 42 (23–77) | |
| Male, % | 94 (47) | 87 (46) | 7 (43) | 0.816 |
| Congenital heart disease | ||||
| Mild, % | 39 (19) | 35 (19) | 4 (25) | 0.548 |
| Moderate, % | 123 (61) | 116 (62) | 8 (50) | 0.352 |
| Severe, % | 40 (20) | 35 (19) | 4 (25) | 0.548 |
| New York Heart Association class | ||||
| Class I, % | 97 (48) | 95 (51) | 2 (13) | <0.001 |
| Class ≥ II, % | 105 (52) | 91 (49) | 14 (87) | <0.001 |
| Event history | ||||
| Cardiac surgery, % | 168 (83) | 156 (83) | 12 (75) | 0.363 |
| PM/ICD implantation, % | 17 (8) | 14 (8) | 3 (19) | 0.121 |
| Medication | ||||
| Diuretics, % | 19 (9) | 12 (6) | 7 (44) | <0.001 |
| Antiarrhythmic, % | 62 (31) | 51 (27) | 11 (69) | 0.001 |
| mHealth | ||||
| Smartphone utilisation (%) | 186 (92) | 172 (92) | 14 (87) | 0.369 |
| Wiling to use mHealth (%) | 143 (71) | 131 (70) | 12 (75) | 0.70 |